These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1172 related articles for article (PubMed ID: 22145215)

  • 1. [Targeted therapy of melanoma: fact or fiction?].
    Svajdler M; Rychlý B; Benický M
    Cesk Patol; 2011 Oct; 47(4):165-7. PubMed ID: 22145215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted therapy for melanoma: rational combinatorial approaches.
    Kwong LN; Davies MA
    Oncogene; 2014 Jan; 33(1):1-9. PubMed ID: 23416974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapy resistance mechanisms and therapeutic implications in melanoma.
    Chen G; Davies MA
    Hematol Oncol Clin North Am; 2014 Jun; 28(3):523-36. PubMed ID: 24880945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new standard of care for metastatic melanoma?
    Sharma SP
    Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638559
    [No Abstract]   [Full Text] [Related]  

  • 5. What the Oncologist Needs From the Pathologist for Tyrosine Kinase Inhibitor Therapies.
    Bernicker EH
    Arch Pathol Lab Med; 2019 Sep; 143(9):1089-1092. PubMed ID: 31100016
    [No Abstract]   [Full Text] [Related]  

  • 6. Melanoma Treatments: Advances and Mechanisms.
    Marzuka A; Huang L; Theodosakis N; Bosenberg M
    J Cell Physiol; 2015 Nov; 230(11):2626-33. PubMed ID: 25899612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melanoma and search for therapeutic targets].
    de la Fouchardière A
    Ann Pathol; 2011 Nov; 31(5 Suppl):S123-4. PubMed ID: 22054449
    [No Abstract]   [Full Text] [Related]  

  • 8. [BRAF mutation testing for the choice of melanoma treatment].
    Imianitov EN
    Arkh Patol; 2012; 74(5):65-71. PubMed ID: 23342664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma treatment's changing landscape.
    Jenks S
    J Natl Cancer Inst; 2014 Jun; 106(6):dju176. PubMed ID: 24907389
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
    Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
    J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic and predictive markers of malignant melanoma].
    Rásó E; Barbai T; Gyõrffy B; Tímár J
    Magy Onkol; 2013 Jun; 57(2):79-83. PubMed ID: 23795352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting metastatic melanoma.
    Flaherty KT
    Annu Rev Med; 2012; 63():171-83. PubMed ID: 22034865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New therapeutic options in the medical management of advanced melanoma.
    Lutzky J
    Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standing on the shoulders of giants.
    Turajlic S
    Nat Med; 2019 Mar; 25(3):357. PubMed ID: 30842663
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.
    Lang J; MacKie RM
    J Invest Dermatol; 2005 Sep; 125(3):575-9. PubMed ID: 16117801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapies in melanoma.
    Moschos SJ; Pinnamaneni R
    Surg Oncol Clin N Am; 2015 Apr; 24(2):347-58. PubMed ID: 25769717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma.
    Parakh S; Murphy C; Lau D; Cebon JS; Andrews MC
    J Clin Pharm Ther; 2015 Feb; 40(1):121-3. PubMed ID: 25382067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAF inhibitors: research accelerates in wake of positive findings.
    Brower V
    J Natl Cancer Inst; 2010 Feb; 102(4):214-5. PubMed ID: 20145213
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting NRAS in melanoma.
    Kelleher FC; McArthur GA
    Cancer J; 2012; 18(2):132-6. PubMed ID: 22453013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene abnormalities in melanoma and signal transduction antagonists].
    Takada M
    Gan To Kagaku Ryoho; 2013 Apr; 40(4):453-7. PubMed ID: 23894754
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 59.